sever
acut
respiratori
syndrom
coronaviru
sarscov
spike
protein
known
mediat
receptor
interact
immun
recognit
thu
consid
major
target
vaccin
design
spike
protein
play
import
role
viru
entri
viru
receptor
interact
viru
tropism
sensit
diagnosi
sar
essenti
control
diseas
human
recombin
sarscov
antigen
produc
purifi
develop
monoclon
bispecif
monoclon
antibodi
hybridoma
secret
antibodi
fuse
respect
hybridoma
gener
quadroma
sandwich
elisa
form
use
coat
antibodi
biotinyl
detect
antibodi
detect
limit
gml
p
detect
limit
found
coat
antibodi
biotinyl
detect
antibodi
sensit
improv
detect
limit
gml
howev
use
bispecif
monoclon
antibodi
detect
antibodi
conclus
method
describ
studi
allow
sensit
detect
recombin
sar
spike
protein
sandwich
elisa
bispecif
monoclon
antibodi
could
use
diagnosi
patient
suspect
sar
sever
acut
respiratori
syndromecoronaviru
sarscov
rna
viru
contain
posit
sens
singl
strand
rna
genom
kb
viru
contain
sever
structur
protein
spike
protein
nucleocapsid
protein
membran
protein
well
envelop
protein
protein
replic
host
cell
marra
outbreak
sarscov
occur
guangdong
provinc
southern
china
spread
subsequ
countri
asia
europ
north
america
brought
control
due
concert
worldwid
effort
led
world
health
organ
sarscov
caus
agent
sar
human
accord
outbreak
sar
epidem
infect
person
led
death
peopl
fatal
rate
sarscovlik
virus
almost
ident
isol
patient
found
palm
civet
cat
period
recent
chines
horsesho
bat
identifi
import
natur
reservoir
viru
past
year
highli
pathogen
sarscov
identifi
human
anim
li
et
al
yip
et
al
yuan
et
al
peiri
poon
balboni
et
al
vital
step
prevent
control
futur
epidem
block
transmiss
infect
effect
quarantin
polici
turn
depend
upon
earli
diagnosi
confirm
diseas
laboratori
test
poon
et
al
present
serolog
detect
virus
compon
monoclon
antibodi
mab
known
power
method
investig
structur
function
viral
compon
product
mab
specif
sarscov
aid
studi
viral
pathogenesi
develop
diagnost
therapeut
strategi
sinc
develop
serum
antibodi
take
one
three
week
sarscov
infect
li
et
al
b
sensit
assay
detect
viral
nucleic
acid
protein
may
prefer
rapid
detect
sarscov
infect
profil
antibodi
respons
sarscov
well
establish
report
indic
specif
viral
protein
might
better
marker
serolog
detect
infect
sarscov
tan
et
al
lu
et
al
berri
et
al
spike
protein
cov
larg
transmembraneglycoprotein
mediat
receptor
associ
membran
fusion
viral
entri
gallagh
buchmeier
bosch
et
al
colman
lawrenc
play
key
role
infect
target
cell
possess
specif
receptor
gallagh
buchmeier
holm
hofmann
et
al
cellular
receptor
sarscov
receptor
bind
domain
sprotein
identifi
babcock
et
al
two
subunit
sarscov
sprotein
describ
xiao
et
al
huang
et
al
subunit
respons
viru
bind
cellular
receptor
contain
neutral
epitop
wherea
subunit
contain
hydrophob
fusion
peptid
mediat
membran
fusion
follow
receptor
associ
bosch
et
al
earlier
studi
shown
receptor
bind
domain
region
sprotein
induc
neutral
antibodi
product
angiotensinconvert
enzym
bind
viru
entri
et
al
deplet
receptor
bind
domain
reduc
significantli
humor
immun
respons
indic
domain
domin
induc
neutral
antibodi
lu
et
al
sarscov
subunit
highli
conserv
tenresidu
sequenc
kwpw
wy
vwl
rich
aromat
amino
acid
tryptophan
residu
last
five
residu
region
probabl
begin
membranespan
domain
also
call
transmembran
domain
sainz
et
al
siu
et
al
inform
avail
mab
detect
sarscov
kammila
et
al
howev
limit
inform
sensit
detect
method
sarscov
sprotein
hybridoma
monoclon
antibodi
mab
quadroma
proudc
construct
bispecif
mab
bsmab
sarscov
antigen
aim
studi
evalu
sensit
elisa
use
panel
mab
andor
bsmab
detect
sarscov
antigen
vitro
fetal
bovin
serum
purchas
paa
laboratori
etobicok
canada
streptomycinpenicillinglutamin
obtain
gibco
burlington
canada
polyethylen
glycol
hat
ht
supplement
goat
antimous
igg
conjug
horseradish
peroxidas
hrpo
bovin
serum
albumin
fluorescein
isothicyan
tetramethylrhodamin
isothicyan
horseradish
peroxidas
type
iv
maminopheylboron
acid
agaros
bind
capac
hrpo
mgml
gel
protein
gsepharos
long
chainsulfosuccinimidyl
nh
biotin
low
molecular
dextran
sulphat
rpmi
media
rabid
antichicken
igyhrpo
obtain
sigma
st
loui
mo
usa
cell
strainer
collect
spleen
streptavidinhrpo
obtain
bd
bioscienc
pharmingen
mississauga
canada
imab
tm
bag
obtain
biovectra
charlottetown
pe
canada
tetramethylbenzidin
hydrogen
peroxid
h
detect
reagent
obtain
kpl
laboratori
gaithersburg
md
usa
slidealyz
r
dialysi
obtain
form
pierc
rockford
il
usa
dialysi
tube
mw
cut
obtain
biodesign
inc
carmel
ny
usa
imac
protein
purif
resin
purchas
form
thermo
scientif
rockford
il
usa
hybridoma
kindli
provid
nation
microbiolog
laboratori
health
canada
winnipeg
mb
canada
sarscov
nucleotid
sequenc
codon
optim
prokaryot
express
synthes
geneart
burlington
canada
optim
gene
amplifi
pcr
clone
proper
read
frame
vector
along
tag
ctermin
higher
express
protein
inclus
bodi
escherichia
coli
recombin
clone
analyz
restrict
digest
fragment
map
correct
clone
select
protein
express
protein
purif
done
imac
chromatographi
inclus
bodi
nonglycosyl
protein
use
gener
mab
bsmab
develop
sensit
immunoassay
purifi
electrophores
sdspage
use
polyacrylamid
gel
check
puriti
accord
publish
method
laemmli
protein
band
electroblot
onto
hybond
ecl
nitrocellulos
membran
towbin
et
al
membran
block
skim
milk
pb
contain
tween
pbst
h
membran
wash
pbst
incub
h
antisarscov
gml
wash
pbst
nitrocellulos
membran
incub
rabbit
h
incub
carri
room
temperatur
final
membran
wash
pb
electrochemiluminesc
detect
perform
visual
specif
bind
immun
perform
accord
guidelin
institut
anim
care
use
committe
briefli
femal
balbc
mice
charl
river
immun
intraperiton
time
g
antigen
day
use
complet
incomplet
freund
adjuv
respect
g
antigen
day
use
pb
ph
polyclon
antibodi
antigen
measur
mous
serum
use
indirect
elisa
mice
highest
titer
spleenectom
day
last
antigen
inject
spleenocyt
fuse
myeloma
cell
ratio
use
wv
polyethylen
glycol
peg
kohler
milstein
five
sarscov
mab
develop
use
subsequ
product
quadroma
isotyp
mab
determin
use
isotyp
specif
hrpo
conjug
antibodi
cell
line
known
secret
monospecif
antihrpo
hybridoma
obtain
late
dr
c
milstein
medic
research
council
molecular
biolog
cambridg
unit
kingdom
cell
line
known
secret
monospecif
hybridoma
kindli
provid
nml
winnipeg
mb
canada
antihrpo
wellcharacter
rat
hybridoma
select
previous
drug
resist
make
sensit
aminopterin
hat
medium
antisarscov
mous
hybridoma
bind
receptor
bind
domain
region
sar
cov
berri
et
al
two
cell
line
chosen
develop
quadroma
hybridoma
hybridoma
kammila
et
al
develop
quadroma
involv
maintain
two
hybridoma
cell
line
antihrpo
respect
logarithm
growth
phase
contain
rpmi
medium
fetal
bovin
serum
fb
c
supplement
co
trypan
blue
stain
observ
cell
use
fusion
stock
solut
tetramethyl
rhodamin
isothiocyan
tritc
mgml
fluorescein
isothiocyan
fitc
mgml
dilut
ratio
use
work
solut
follow
step
publish
earlier
follow
success
complet
quadroma
fusion
tang
et
al
briefli
cellsml
hybridoma
hybridoma
resuspend
separ
rpmi
ph
respect
hybridoma
label
tritc
red
fluoresc
hybridoma
label
fitc
green
fluoresc
follow
min
incub
c
co
incub
hybridoma
cell
suspens
wash
mix
ml
tube
centrifug
g
min
two
ml
peg
ad
cell
pellet
dropwis
period
min
gentl
mix
ad
peg
cell
suspens
place
c
co
incub
min
follow
addit
ml
fb
free
rpmi
medium
dilut
toxic
effect
peg
flow
cytomet
epic
elit
cell
sorter
coulter
hialeah
usa
argon
ion
nm
air
cool
laser
cross
cancer
institut
univers
alberta
use
sort
cell
dual
fluoresc
seed
cellwel
well
steril
tissu
cultur
plate
rpmi
contain
fb
plate
incub
c
co
clone
screen
twice
use
direct
elisa
see
section
clone
quadroma
carri
use
limit
dilut
method
three
clone
select
reclon
time
select
posit
highli
specif
quadroma
secret
bsmab
sarscov
antigen
elisa
techniqu
indirect
elisa
hybridoma
cultur
supernat
assay
bind
sarscov
coat
well
plate
plate
coat
l
purifi
gml
mm
carbon
buffer
ph
incub
c
overnight
thorough
wash
pbst
buffer
time
remain
site
well
surfac
block
l
block
buffer
wv
bsa
pbst
c
h
wash
l
hybridoma
supernat
dilut
wv
bsa
pbst
ad
well
incub
c
h
follow
addit
wash
step
volum
l
goat
antimous
igg
hrpo
dilut
wv
bsa
pbst
ad
well
incub
c
h
plate
wash
pbst
posit
bind
detect
commerci
tmb
substrat
plate
read
nm
min
use
v
max
elisa
plate
reader
mous
immun
preimmun
sera
dilut
wv
bsa
pbst
use
posit
neg
control
respect
direct
elisa
use
screen
procedur
day
quadroma
fusion
method
involv
coat
elisa
plate
l
gml
sarscov
antigen
mm
carbon
buffer
ph
plate
incub
c
overnight
wash
pbst
block
dialyz
bsa
wv
pbst
c
h
wash
l
serial
dilut
neat
quadroma
supernat
ad
plate
incub
c
h
follow
wash
step
l
gml
dilut
bsa
wv
pbst
hrpo
ad
well
follow
wash
step
final
l
tmb
substrat
ad
posit
quadroma
select
min
color
develop
plate
read
nm
use
elisa
plate
reader
rpmi
media
pb
use
blank
neg
control
well
without
antigen
hrpo
bridg
elisa
measur
activ
bsmab
bind
solid
phase
one
paratop
hrpo
solut
paratop
bsmab
monospecif
antibodi
detect
assay
sinc
crosslink
two
differ
antigen
except
otherwis
indic
incub
step
perform
c
h
wash
five
time
conduct
pbst
step
plate
coat
l
purifi
mab
gml
mm
carbon
buffer
ph
remain
site
well
surfac
block
l
block
buffer
wv
bsa
pbst
volum
l
sarscov
serial
dilut
wv
bsa
pbst
ad
well
follow
addit
l
biotinyl
probe
mab
gml
wv
bsa
pbst
plate
react
streptavidinhrpo
min
tmb
substrat
ad
color
develop
read
nm
min
use
elisa
reader
except
otherwis
indic
incub
step
perform
c
h
wash
five
time
conduct
pbst
step
plate
coat
l
purifi
mab
gml
mm
carbon
buffer
ph
remain
site
well
surfac
block
l
block
buffer
wv
bsa
pbst
c
h
volum
l
sarscov
serial
dilut
wv
bsa
pbst
ad
well
follow
addit
l
bsmabhrpo
complex
gml
wv
bsa
pbst
plate
wash
tmb
substrat
ad
color
develop
read
nm
min
use
elisa
reader
purif
bsmab
quadroma
fuse
use
maminophenylboron
acid
agaros
column
apba
briefli
apba
column
satur
hrpo
captur
bsmab
along
monospecif
antihrpo
mab
elimin
monospecif
speci
follow
short
wash
pb
bound
antibodi
elut
potassium
phosphat
buffer
contain
sorbitol
mab
biotinyl
use
long
arm
biotinaimdo
hexano
ester
volum
g
prote
purifi
mab
pb
ph
ad
l
long
chain
biotin
gml
incub
room
temperatur
h
ten
microlit
glycin
gl
ad
solut
kept
shaker
min
solut
dialyz
slidealyz
pb
ph
c
overnight
valu
repres
mean
experi
done
triplic
comparison
data
perform
use
student
test
signific
defin
p
valu
purifi
analyz
sdspage
fig
specif
determin
western
blot
demonstr
antisarscov
mab
bind
strongli
antigen
fig
similar
result
also
found
antisarscov
mab
data
shown
crossreact
viral
recombin
protein
includ
nonstructur
protein
deriv
dengu
viru
ebola
viru
data
shown
hybridoma
produc
antibodi
sarscov
establish
success
spleenocyt
follow
immun
antigen
among
six
hybridoma
sarscov
antigen
three
hybridoma
show
approxim
higher
titer
tabl
show
isotyp
sarscov
mab
yield
sarscov
purifi
mab
respect
hybridoma
secret
mab
name
fuse
respect
hybridoma
produc
quadroma
accord
method
describ
previous
tang
et
al
select
done
direct
elisa
proport
doubl
posit
cell
bispecif
fusion
rang
data
shown
reclon
process
involv
clone
quadroma
limit
dilut
one
cell
per
well
plate
quadroma
tabl
isotyp
antisarscov
spike
protein
mab
elisa
exhibit
polyploidi
henc
shown
high
level
instabl
process
repeat
reclon
help
develop
identif
strong
bsmab
secret
quadroma
sensit
purifi
bsmabhrpo
complex
examin
elisa
demonstr
od
absorb
unit
valu
two
quadroma
ngml
pb
ngml
pb
respect
fig
quadroma
clone
obtain
fusion
select
base
higher
od
valu
purifi
yield
bsmab
approxim
mgml
cultur
supernat
subsequ
use
develop
immunoassay
fig
illustr
sandwich
elisa
detect
sarscov
antigen
use
mab
coat
antibodi
biotinyl
mab
detect
antibodi
limit
detect
gml
p
fig
similar
result
found
mab
use
coat
antibodi
biotinyl
use
detect
antibodi
gml
p
fig
fig
illustr
sandwich
elisa
detect
sarscov
antigen
use
mab
coat
antibodi
bsmabhrpo
complex
detect
antibodi
limit
detect
gml
fig
similar
result
found
mab
use
coat
antibodi
bsmabhrpo
complex
use
detect
antibodi
gml
p
fig
sarscov
sprotein
essenti
structur
protein
viru
import
function
relationship
pathogenesi
sar
ho
et
al
play
signific
role
viral
infect
may
also
use
potenti
target
vaccin
sprotein
sarscov
heavili
glycosyl
contain
mani
disulfid
bond
spiga
et
al
krokhin
et
al
tripet
et
al
ying
et
al
howev
difficult
obtain
sprotein
express
eukaryot
system
would
otherwis
ideal
detect
antispik
antibodi
vitro
fig
elisa
detect
sarscov
antigen
use
biotinyl
mab
sandwich
elisa
antisarscov
mab
coat
antibodi
mab
label
biotin
detect
antibodi
biotinyl
mab
detect
use
streptavidinhrpo
b
sandwich
elisa
antisarscov
mab
coat
antibodi
anoth
mab
label
biotin
biotinyl
mab
detect
use
streptavidinhrpo
result
express
absorb
read
nm
wavelength
arrow
indic
limit
detect
suggest
nglycan
sprotein
could
signific
effect
antigen
presenc
contribut
proper
fold
biolog
function
glycoprotein
fragment
sprotein
nonglycosyl
express
bacteria
could
also
maintain
antigen
zhou
et
al
lu
et
al
identif
neutral
epitop
sprotein
great
import
vaccin
design
also
understand
antisarscov
humor
immun
respons
demonstr
receptor
bind
domain
residu
contain
immunodomin
b
cell
epitop
recogn
neutral
antibodi
sui
et
al
et
al
neutral
antibodi
rais
success
mice
immun
use
prokaryot
express
sarscov
zhou
et
al
current
mani
diagnost
method
detect
sar
realtim
rtpcr
elisa
viru
lysat
antigen
howev
rtpcr
expens
small
rural
hospit
also
use
found
limit
clinic
set
due
difficulti
sampl
collect
furthermor
inconsist
read
lower
level
concentr
fig
elisa
detect
sarscov
antigen
use
bsmab
sandwich
elisa
antisarscov
mab
coat
antibodi
bsmabhrpo
complex
detect
antibodi
b
sandwich
elisa
antisarscov
mab
coat
antibodi
bsmabhrpo
complex
detect
antibodi
color
develop
use
tmb
substrat
result
express
absorb
read
nm
wavelength
arrow
indic
limit
detect
observ
poon
et
al
peptid
base
sar
elisa
howev
demonstr
distinct
advantag
huanga
et
al
peptid
easi
safe
prepar
compar
whole
viru
lysat
new
assay
improv
test
sensit
reliabl
sprotein
project
viral
surfac
major
neutral
antigen
known
cov
play
import
role
initi
stage
infect
form
characterist
corona
larg
distinct
spike
viral
envelop
et
al
also
mediat
initi
stage
viral
entri
serv
major
target
recogn
humor
cellular
immun
respons
li
et
al
b
develop
murin
mab
recogn
sarscov
antigen
measur
elisa
describ
current
studi
sandwich
elisa
use
panel
mab
bsmab
develop
use
recombin
sarscov
antigen
product
bsmab
bifunct
immunoconjug
bear
two
differ
bind
site
paratop
sarscov
sprotein
avoid
need
random
chemic
coupl
strategi
develop
bsmab
first
kind
sarscov
use
subsequ
part
assay
presenc
intrins
enzym
bind
activ
within
bsmab
result
clear
background
make
use
tool
develop
specif
diagnosi
sarscov
assay
abl
detect
antigen
first
suggest
assay
could
use
detect
whole
viru
soon
infect
occur
rather
antigen
secret
bodi
fluid
earlier
studi
also
show
differ
combin
mab
bsmab
igi
polyclon
antibodi
detect
sarscov
nucleocapsid
protein
immunoswab
assay
kammila
et
al
sandwich
elisa
palaniyappan
et
al
sensit
pgml
recombin
np
antigen
vitro
antibodi
nucleocapsid
protein
longer
shelf
life
occur
greater
abund
sar
patient
antibodi
viral
compon
sprotein
membran
envelop
protein
rota
et
al
may
due
presenc
higher
level
nucleocapsid
protein
compar
viral
protein
sarscov
infect
recombin
nucleocapsid
proteinbas
igg
elisa
sensit
recombin
igg
elisa
serodiagnosi
sarscov
yu
et
al
duet
highli
immunogen
region
may
help
explain
present
result
show
less
sensit
sprotein
detect
compar
previou
nucleocapsid
protein
detect
studi
palaniyappan
et
al
present
result
suggest
mab
bsmab
could
use
reagent
diagnosi
sarscov
well
function
analysi
sprotein
infect
immunolog
studi
two
differ
mab
two
target
sasrcov
specif
antigen
nucleocapsid
protein
sprotein
remain
evalu
conclus
mab
bsmab
sarscov
antigen
gener
fusion
technolog
evalu
elisa
use
serolog
diagnosi
present
studi
show
develop
novel
sandwich
elisa
test
potenti
use
diagnosi
sarscov
infect
base
bsmab
recogn
simultan
sprotein
sarscov
enzym
peroxidas
